MedTrace Logo

Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma

NCT04956367 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-07-09

No results posted yet for this study

Summary

This study determined the efficacy of ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma versus ablative fractional carbon dioxide laser with placebo in the treatment of striae gravidarum of postpartum Filipino women.

Conditions

  • Striae Gravidarum

Interventions

PROCEDURE

Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma

Carbon dioxide laser (Smaxel.878.4810) was FDA-approved device used in dermatology practice. PRP was described as having growth factors to be used to promote healing.

DEVICE

CO2 laser with PRP

CO2 laser with PRP

DEVICE

CO2 laser with placebo

CO2 laser with placebo

Sponsors & Collaborators

  • Jose R. Reyes Memorial Medical Center

    lead OTHER_GOV

Principal Investigators

  • Ivan Arni C Preclaro, MD · Jose R. Reyes Memorial Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-10-31
Completion
2019-11-30
FDA Device
Yes

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04956367 on ClinicalTrials.gov